182
Views
8
CrossRef citations to date
0
Altmetric
Letters to the Editor

De novo CD5+ diffuse large B-cell lymphoma: a distinct subset with adverse features, poor failure-free survival and outcome with conventional therapy

&
Pages 161-163 | Received 04 Sep 2009, Accepted 09 Sep 2009, Published online: 28 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fangwen Zhang, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, Jingjing Wu, Zhenchang Sun, Fei Kong, Liangliang Ren & Mingzhi Zhang. (2019) Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens. Blood and Lymphatic Cancer: Targets and Therapy 9, pages 33-43.
Read now

Articles from other publishers (7)

Hee Young Na, Ji-Young Choe, Sun Ah Shin, Hyun-Jung Kim, Jae Ho Han, Hee Kyung Kim, So Hee Oh & Ji Eun Kim. (2019) Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors. PLOS ONE 14:10, pages e0224247.
Crossref
Beenu Thakral, L. Jeffrey Medeiros, Parth Desai, Pei Lin, C. Cameron Yin, Guilin Tang, Joseph D. Khoury, Shimin Hu, Jie Xu, Sanam Loghavi, Bei Hu, Yasuhiro Oki & Shaoying Li. (2017) Prognostic impact of CD 5 expression in diffuse large B‐cell lymphoma in patients treated with rituximab‐ EPOCH . European Journal of Haematology 98:4, pages 415-421.
Crossref
Zijun Y. Xu-Monette, Meifeng Tu, Kausar J. Jabbar, Xin Cao, Alexandar Tzankov, Carlo Visco, Qingqing Cai, Santiago Montes-Moreno, Yuji An, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Xiaoying Zhao, Michael B. Møller, John P. Farnen, Jane N. Winter, Miguel A. Piris, Roberto N. Miranda, L. Jeffrey Medeiros & Ken H. Young. (2015) Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries . Oncotarget 6:8, pages 5615-5633.
Crossref
Adina M. Cioc, Jos? Jessurun, Gregory M. Vercellotti & Stefan E. Pambuccian. (2014) De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology. Diagnostic Cytopathology 42:3, pages 259-267.
Crossref
Dmitry V. Kazakov, Pavel Jindra, Werner Kempf, Boris Kreuzberg, Ondrej Sebera, Marianne Tinguely & Michal Michal. (2014) De Novo CD5+ Diffuse Large B-Cell Lymphoma With Cutaneous Involvement. Pathology Case Reviews 19:4, pages 200-203.
Crossref
Preetesh Jain, Luis E. Fayad, Andreas Rosenwald, Ken H. Young & Susan O'Brien. (2013) Recent advances in de novo CD5 + diffuse large B cell lymphoma . American Journal of Hematology 88:9, pages 798-802.
Crossref
Anamarija M. Perry, Zdravko MitrovicWing C. Chan. (2012) Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma. Cancer Control 19:3, pages 214-226.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.